Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Evoq Remedies Limited has informed BSE that its trading window will be closed for all directors, promoters, designated persons, and insiders starting Wednesday, 1st April 2026. The window will remain shut until 48 hours after the declaration and publication of the company's audited financial results for the half year and full year ended 31st March 2026. The move is in compliance with Clause 4 of Schedule B of SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's own insider trading code. The intimation has been signed by Managing Director Bhumishth Patel.
This is a routine regulatory compliance announcement ahead of the upcoming audited results and is not expected to have a material impact on the stock price. Shareholders should note that key insiders cannot trade in the stock during this blackout period, which signals that results are likely to be declared in the coming weeks.